Terns Pharmaceuticals Inc (TERN)
7.099
+0.16
(+2.29%)
USD |
NASDAQ |
Nov 04, 16:00
7.055
-0.04
(-0.62%)
After-Hours: 20:00
Terns Pharmaceuticals Market Cap: 496.47M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 488.38M |
| October 31, 2024 | 482.75M |
| October 30, 2024 | 484.86M |
| October 29, 2024 | 484.16M |
| October 28, 2024 | 458.12M |
| October 25, 2024 | 469.38M |
| October 24, 2024 | 475.01M |
| October 23, 2024 | 491.90M |
| October 22, 2024 | 527.79M |
| October 21, 2024 | 509.49M |
| October 18, 2024 | 521.46M |
| October 17, 2024 | 527.79M |
| October 16, 2024 | 538.34M |
| October 15, 2024 | 534.83M |
| October 14, 2024 | 536.23M |
| October 11, 2024 | 539.75M |
| October 10, 2024 | 521.10M |
| October 09, 2024 | 554.53M |
| October 08, 2024 | 549.60M |
| October 07, 2024 | 552.42M |
| October 04, 2024 | 581.98M |
| October 03, 2024 | 577.05M |
| October 02, 2024 | 577.05M |
| October 01, 2024 | 570.01M |
| September 30, 2024 | 586.90M |
| Date | Value |
|---|---|
| September 27, 2024 | 601.68M |
| September 26, 2024 | 622.79M |
| September 25, 2024 | 650.94M |
| September 24, 2024 | 676.27M |
| September 23, 2024 | 684.72M |
| September 20, 2024 | 705.13M |
| September 19, 2024 | 706.53M |
| September 18, 2024 | 718.50M |
| September 17, 2024 | 677.68M |
| September 16, 2024 | 662.20M |
| September 13, 2024 | 630.18M |
| September 12, 2024 | 669.24M |
| September 11, 2024 | 751.57M |
| September 10, 2024 | 790.28M |
| September 09, 2024 | 641.79M |
| September 06, 2024 | 549.60M |
| September 05, 2024 | 524.97M |
| September 04, 2024 | 515.83M |
| September 03, 2024 | 508.79M |
| August 30, 2024 | 536.23M |
| August 29, 2024 | 540.46M |
| August 28, 2024 | 541.86M |
| August 27, 2024 | 559.46M |
| August 26, 2024 | 582.68M |
| August 23, 2024 | 578.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
37.92M
Minimum
May 11 2022
790.28M
Maximum
Sep 10 2024
350.98M
Average
342.13M
Median
May 02 2024
Market Cap Benchmarks
| Eli Lilly and Co | 765.28B |
| Viking Therapeutics Inc | 7.036B |
| Biomarin Pharmaceutical Inc | 12.58B |
| Elite Pharmaceuticals Inc | 544.93M |
| Verrica Pharmaceuticals Inc | 61.02M |
Market Cap Related Metrics
| Price to Book Value | 2.270 |
| Price | 7.099 |
| Earnings Yield | -18.71% |